Mineralys Therapeutics Inc (NAS:MLYS)
$ 30.4 -0.050 (-0.16%) Market Cap: 2.68 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 37/100

Q1 2026 Mineralys Therapeutics Inc Earnings Call Transcript

May 6, 2026 / 08:30 PM GMT
Release Date Price: $30.12 (+2.87%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MLYS.OQ - Mineralys Therapeutics Inc
Q1 2026 Mineralys Therapeutics Inc Earnings Call
May 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Minoralis Therapeutics first quarter 2026 conference call. It is now my pleasure to introduce your host, Dan Ferry of Life Science Advisors. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. I would like to welcome everyone joining us today for our first-quarter 2026 conference call.

This afternoon, after the close of market trading, we issued a press release providing our first-quarter 2026 financial results and business updates.

A replay of today's call will be available on the Investors section of our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot